Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data validation
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
1.5.2.1 Paid sources
1.5.2.2 Public sources
Chapter 2 Executive Summary
2.1 Dyspepsia drugs industry 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Indication trends
2.1.4 Drug type trends
2.1.5 Medication trends
2.1.6 Mode trends
2.1.7 Distribution channel trends
Chapter 3 Dyspepsia Drugs Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of dyspepsia
3.2.1.2 Growing aging population
3.2.1.3 Rising preference for over-the-counter (OTC) medications
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects associated with the dyspepsia drugs
3.2.2.2 Availability of alternative therapies
3.3 Growth potential analysis
3.3.1 By indication
3.3.2 By drug type
3.3.3 By medication
3.3.4 By mode
3.3.5 By distribution channel
3.4 Regulatory landscape
3.5 Pricing analysis
3.6 Epidemiology
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic dashboard, 2023
Chapter 5 Dyspepsia Drugs Market Estimates and Forecast, By Indication, 2018-2032 (USD Million)
5.1 Key trends, by indication
5.2 Functional dyspepsia
5.3 Organic dyspepsia
Chapter 6 Dyspepsia Drugs Market Estimates and Forecast, By Drug Type, 2018-2032 (USD Million)
6.1 Key trends, by drug type
6.2 Proton pump inhibitors
6.3 H-2-receptor antagonists
6.4 Antacids
6.5 Antibiotics
6.6 Prokinetics
6.7 Antidepressants
Chapter 7 Dyspepsia Drugs Market Estimates and Forecast, By Medication, 2018-2032 (USD Million)
7.1 Key trends, by medication
7.2 Branded
7.3 Generic
Chapter 8 Dyspepsia Drugs Market Estimates and Forecast, By Mode, 2018-2032 (USD Million)
8.1 Key trends, by mode
8.2 Over-the-counter
8.3 Prescription
Chapter 9 Dyspepsia Drugs Market Estimates and Forecast, By Distribution Channel, 2018-2032 (USD Million)
9.1 Key trends, by distribution channel
9.2 Retail pharmacies
9.3 Hospital pharmacies
9.4 Online pharmacies
Chapter 10 Dyspepsia Drugs Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 Takeda Pharmaceutical Company Limited
11.2 AstraZeneca plc
11.3 Salix Pharmaceuticals, Inc.
11.4 Abbott Laboratories
11.5 Pfizer Inc.
11.6 Sanofi SA
11.7 Procter & Gamble
11.8 Haleon plc
11.9 ANI Pharmaceuticals, Inc.
11.10 Dr Reddy’s Laboratories Ltd.
